Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. | Biomed Res Int | 2022 | 36398067 | PubTator, text mining | PubMed |
| Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis. | Nat Commun | 2022 | 36396631 | PubTator, text mining | PubMed |
| MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. | Front Immunol | 2022 | 36389712 | PubTator, text mining | PubMed |
| microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection. | Front Cell Infect Microbiol | 2022 | 36389170 | PubTator, text mining | PubMed |
| Genome-wide mutational analysis of Chikungunya strains from 2016 to 2017 outbreak of central India: An attempt to elucidate the immunological basis for outbreak. | Heliyon | 2022 | 36387532 | PubTator, text mining | PubMed |
| TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma. | BMC Endocr Disord | 2022 | 36380313 | PubTator, text mining | PubMed |
| Glia as antigen-presenting cells in the central nervous system. | Curr Opin Neurobiol | 2022 | 36371828 | PubTator, text mining | PubMed |
| Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational Approaches. | Vaccines (Basel) | 2022 | 36366359 | PubTator, text mining | PubMed |
| Loss of the Nuclear Envelope Protein LAP1B Disrupts the Myogenic Differentiation of Patient-Derived Fibroblasts. | Int J Mol Sci | 2022 | 36362402 | PubTator, text mining | PubMed |
| The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma. | Cells | 2022 | 36359834 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals cellular heterogeneity and molecular stratification of cervical cancer. | Commun Biol | 2022 | 36357663 | PubTator, text mining | PubMed |
| Immune and spermatogenesis-related loci are involved in the development of extreme patterns of male infertility. | Commun Biol | 2022 | 36357561 | PubTator, text mining | PubMed |
| Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment. | World J Gastroenterol | 2022 | 36353205 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomic profiling of multiple organs in a rhesus macaque model of SARS-CoV-2 infection. | Zool Res | 2022 | 36349357 | PubTator, text mining | PubMed |
| Identification and analysis of novel endometriosis biomarkers via integrative bioinformatics. | Front Endocrinol (Lausanne) | 2022 | 36339397 | PubTator, text mining | PubMed |
| Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. | Front Genet | 2022 | 36338983 | PubTator, text mining | PubMed |
| SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein. | Immunoinformatics (Amst) | 2022 | 36337685 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases. | Clin Transl Med | 2022 | 36336787 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 Structural Proteins and their Potential Cross-reactivity with Emerging Variants and other Human Coronaviruses. | Arch Med Res | 2022 | 36336501 | PubTator, text mining | PubMed |
| Narcolepsy and H1N1 influenza immunology a decade later: What have we learned? | Front Immunol | 2022 | 36311717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=32